Cardiac Development, Structure and Function

Loading the player...

2018 Guideline on the Management of Blood Cholesterol

Sidney C. Smith, MD, past president of the American Heart Association, and Neil J. Stone, MD discuss the new 2018 Guideline on the Management of Blood Cholesterol, which was published during Scientific Sessions 2018 in Chicago.

Science NewsView All Science News

Evaluation and Management of the Child and Adult With Fontan Circulation
07/01/2019 | Patients born with single ventricle congenital heart disease often receive the Fontan operation, which connects venous return directly to...
ATVB | Featured Articles | July 2019
06/28/2019 | ATVB July 2019 Editor's Pick and Featured Article
Cardiomyopathy in Children: Classification and Diagnosis
05/28/2019 | This statement focuses on diagnosis and classification of cardiomyopathy (heart muscle disease) in children, where research is clarifying...

BCVS 2019 Scientific Sessions

Basic Cardiovascular Sciences 2019 Scientific Sessions
July 29–Aug. 1, 2019
Boston, Massachusetts
 

Learn about BCVS Scientific Sessions

Related Councils

Council on Basic Cardiovascular Sciences (BCVS)

Joseph C. Wu, MD, PhD, FAHA

The American Heart Association (AHA) created the Council on Basic Cardiovascular Sciences (BCVS) in 1999 to promote research and education. Our goal is to improve understanding of mechanisms of basic cardiovascular regulation to support the development of new therapies and insights into clinical cardiovascular disease. Special emphasis is placed on integrating molecular/cellular and physiological approaches to address problems relating to functional genomics, cell signaling, myocardial biology, circulatory physiology, pathophysiology and peripheral vascular disease.

Joseph C. Wu, MD, PhD, FAHA
Chair, Council on Basic Cardiovascular Sciences
 

BCVS Scientific Sessions       Circulation Research       BCVS Council Awards

Council on Genomic and Precision Medicine (GPM)

Thomas J. Wang, MD, FAHA

The mission of the American Heart Association Council on Genomic and Precision Medicine (GPM) is to advance the discovery and translation of biological insights gained from genetics and omics technologies to improve cardiovascular and brain health. Our constituency’s expertise spans across genetics, genomics, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, population health, clinical genetics and genomic medicine, with the ultimate goal of more precise risk prediction, treatment and prevention for patients and the population. Integral to the American Heart Association’s goals, the GPM Council provides a premier inter-disciplinary forum promoting and integrating new knowledge from molecules to populations in translational cardiovascular science and precision medicine.

Thomas J. Wang, MD, FAHA
Chair, Council on Genomic and Precision Medicine

Scientific Sessions       Circulation: Genomic and Precision Medicine      GPM Council Awards